MET and cancer: To explore other possible mechanisms, we attempted to analyze the correlation of BICD1 downregulation with a couple of markers involved in various pathways associated with cancer progression, including the immune checkpoint, MET, STAT, and MTOR pathways, in the TCGA LGG cohort.